Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs.

Yoko Ibuka, A David Paltiel, Alison P Galvani
Author Information
  1. Yoko Ibuka: Yale University School of Medicine, New Haven, CT, USA (YI, ADP, APG)
  2. A David Paltiel: Yale University School of Medicine, New Haven, CT, USA (YI, ADP, APG)
  3. Alison P Galvani: Yale University School of Medicine, New Haven, CT, USA (YI, ADP, APG)

Abstract

No abstract text available.

References

  1. Clin Ther. 2008 Feb;30(2):341-57 [PMID: 18343273]
  2. Health Technol Assess. 2003;7(35):iii-iv, xi-xiii, 1-170 [PMID: 14609480]
  3. Emerg Infect Dis. 1999 Sep-Oct;5(5):659-71 [PMID: 10511522]
  4. Pediatrics. 1999 Jun;103(6):e73 [PMID: 10353970]
  5. MMWR Recomm Rep. 2002 Apr 12;51(RR-3):1-31 [PMID: 12002171]
  6. Vaccine. 2006 Feb 13;24(7):1035-43 [PMID: 16183177]
  7. Vaccine. 2010 Mar 11;28(12):2367-9 [PMID: 20085833]
  8. Emerg Infect Dis. 2006 Oct;12(10):1548-58 [PMID: 17176570]
  9. Health Policy Plan. 2005 Jan;20(1):1-13 [PMID: 15689425]
  10. Pharmacoeconomics. 2008;26(2):163-78 [PMID: 18198935]
  11. Vaccine. 2011 Mar 3;29(11):2149-58 [PMID: 21215340]
  12. Epidemiol Infect. 2008 Jun;136(6):852-64 [PMID: 17634159]
  13. JAMA. 1996 Oct 9;276(14):1172-7 [PMID: 8827972]
  14. Pediatrics. 2001 Aug;108(2):E24 [PMID: 11483834]
  15. Ann Intern Med. 2009 Dec 15;151(12):829-39 [PMID: 20008759]
  16. Am J Epidemiol. 2004 Apr 1;159(7):623-33 [PMID: 15033640]
  17. Health Econ. 2010 May;19(5):518-31 [PMID: 19382106]
  18. Health Econ. 2004 Nov;13(11):1117-24 [PMID: 15386683]
  19. Eur J Health Econ. 2008 Feb;9(1):7-15 [PMID: 17333089]
  20. Rev Panam Salud Publica. 2009 Dec;26(6):518-28 [PMID: 20107706]
  21. Am J Med. 2005 Jan;118(1):68-77 [PMID: 15639212]
  22. Pharmacoeconomics. 2008;26(3):191-215 [PMID: 18282015]
  23. J Infect. 2010 Jan;60(1):26-35 [PMID: 19818365]
  24. Pediatrics. 2000 Nov;106(5):973-6 [PMID: 11061762]
  25. Pharmacoeconomics. 2008;26(1):45-56 [PMID: 18088158]
  26. Scand J Infect Dis. 2008;40(9):721-9 [PMID: 18712627]

Grants

  1. R01 AI072706/NIAID NIH HHS

MeSH Term

Cost-Benefit Analysis
Humans
Immunization Programs
Influenza Vaccines
Influenza, Human
Japan
Models, Theoretical
Program Evaluation
Public Health Practice
United States
Vaccination

Chemicals

Influenza Vaccines